logo-loader
viewWesfarmers Ltd

S&P/ASX 200 futures strong heading into the last session of the month

The S&P 500 closed up 3.35% and the Nasdaq Composite closed up 3.62%.

Wesfarmers Ltd - S&P/ASX 200 futures strong heading into the last session of the month
The ASX 200 posted one of its largest daily gains ever yesterday at +7.00%

S&P/ASX 200 (INDEXASX:XJO) (ASX:XJO) futures are up around 3.5% looking to continue yesterday's solid performance of +7.00% to 5,181.40.

US markets were positive overnight, with a gradual rally over the day.

The S&P 500 Index (INDEX:. INX) closed at 2,626.65, +85.18 or up 3.35% and the Nasdaq Composite (INDEXNASDAQ: .IXIC) closed at 7,774.15, +271.77 or up 3.62%.

Today is the last trading day of the month and will look to continue yesterday's positive momentum thanks to the $130 billion additional government stimulus. 

The highlight of the stimulus was that companies can access $1,500 per week for their employees for 6 months if they can show their business has been affected by the virus.

In company news this morning, Wesfarmers Ltd (ASX:WES) has sold another 5.2% of its stake in Coles Group Ltd (ASX:COL) for $15.39 per share raising $1.06 billion.

Wesfarmers still retains a 4.9% interest in Coles.

 

 

Quick facts: Wesfarmers Ltd

Price: 42.3 AUD

ASX:WES
Market: ASX
Market Cap: $47.96 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Kazia Therapeutics working on moving its flagship Paxalisib drug into...

  Kazia Therapeutics Ltd's (ASX:KZA) James Garner speaks to Proactive's Andrew Scott after releasing a poster presentation of interim data from the ongoing phase II study of Paxalisib in glioblastoma at the prestigious American Society of Clinical Oncology (ASCO) annual meeting. Analysis...

2 hours, 39 minutes ago

2 min read